[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637024":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":50,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":63,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University of Minnesota","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cardiac surgery patients",null,"The study uses a within-patient repeated-measures design, where each patient serves as their own control across the three timepoints. The following measures will be recorded:\n\n* SpHb, Perfusion Index, SpO₂ from Masimo Radical-7 (timestamp to HH:MM:SS)\n* FloTrac cardiac index from Edwards HemoSphere\n* ABG hemoglobin, SaO₂, PaO₂, and lactate from ABL analyzer\n* Continuous cardiac index from Swan-Ganz catheter\n* Mean arterial pressure, heart rate and rhythm\n* Patient temperature from the bladder\n* Pressor requirements",[13],"Device: SpHb monitor",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","SpHb monitor","The SpHb monitor is an FDA approved device being used according to its approved indications. No additional invasive procedures, blood draws, or interventions are performed for research purposes.",[9],[21],{"name":22,"affiliation":5,"role":23},"Benjamin Gorbaty, MD","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Sherilyn Landree","CONTACT","(612) 282-3705","landr184@umn.edu",[31],{"facility":5,"status":10,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Minneapolis","Minnesota","55455","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-93.26384,44.97997,{"lat":41,"lon":40},[44],{"name":26,"role":27,"phone":45,"phoneExt":10,"email":29},"612-282-3705",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100637024","validation-and-feasibility-of-noninvasive-oxygen-delivery-index-monitoring-in-cardiac-surgery-patients-100637024",false,"NCT07573306","Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery Patients","Inclusion Criteria:\n\n* Adults ≥ 18 years undergoing cardiac surgery\n* Placement of pulmonary artery catheter with continuous cardiac output (CCO) as part of routine clinical care\n* Placement of arterial line with FloTrac as part of routine clinical care\n* Availability of ≥ 3 arterial blood gas samples at specified timepoints\n\nExclusion Criteria:\n\n* Mechanical circulatory support planned or in use (IABP, Impella, ECMO)\n* Patients without BOTH pulmonary artery catheter with CCO and arterial line with FloTrac\n* Patients who are Research Opt-Out","ALL","18 Years",{"count":57,"type":58},150,"ESTIMATED","OBSERVATIONAL","This study will establish the feasibility and preliminary validity of real-time oxygen delivery index (DO₂i) monitoring using noninvasive hemoglobin (SpHb, Masimo) and minimally invasive cardiac output (FloTrac, Edwards) in cardiac surgery patients.",[62],"Cardiac Surgery","NOT_YET_RECRUITING","2026-08-17",{"date":66,"type":67},"2026-08-18","ACTUAL",{"date":69,"type":58},"2026-10-15",{"date":71,"type":58},"2027-08-01",{"name":5,"class":6},1]